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Molecular mechanism in b-cell development: the role
of Pdx1, Ngn3 and Pax4 proteins
INTRODUCTION
Insulin-producing pancreatic b-cells are predominant and the mostessential cell type of endocrine pancreas. Together with other endo-
crine cell types (glucagon-producing a-cells, somatostatin-producing
d-cells and pancreatic polypeptide-producing PP cells), beta cells are
organized into spherical clusters, each containing about 2000 cells
which are dispersed within the exocrine tissue of pancreas. These
structures are known as islets of Langerhans. The main protein prod-
uct of b-cells is insulin, the only hormone in the body with the ability
to reduce blood glucose level. Insulin deficiency leads towards Diabe-
tes mellitus, a devastating disease that affects approximately 450 mil-
lion people worldwide. In patients suffering from Type I diabetes all
b-cells are destroyed due to strong autoimmune attack. As islet beta
cells per se have a limited capacity for self renewal after postfetal devel-
opment, especially in case of active autoimmune response, beta cell
mass rapidly decreases and causes diabetes. Most diabetic patients to-
day are committed to lifelong insulin therapy. While insulin therapy
offers a means to achieve normoglycemia, only pancreas or islet trans-
plantations represent the actual »cure« for insulin-dependent diabetic
patients. Unfortunately, availability of pancreas donors or islets as a
source for transplantation is acutely limited.
Nevertheless, these patients with time develop severe (diabetic late
complications) life-threatening complications due to the lack of fine
tuned mechanism of glucose sensing and physiologically regulated
insulin release that would maintain constant level of blood glucose.
Therefore diabetes is considered to be an incurable disease, and new
approaches in developing therapy are needed to change that fact. One
of the most promising approaches is cell replacement therapy based
on in vitro differentiation of embryonic stem cells toward insulin-pro-
ducing cells that would display b-cell phenotype. The most common
strategy used by numerous research groups is an attempt to recapitu-
late normal embryonic development of b-cells in the context of
pancreatogenesis in human organism. For that reason, it is essential
to get insight into complex transcriptional networks governed by nu-
merous cell extrinsic and intrinsic signals during formation of an
adult organ from pluripotent cells of an early embryo. Due to strict
limitations of work with human embryonic stem cells and difficulties
in obtaining experimental material, mouse is the most common mo-
del organism for both developmental (in vivo) and differentiational
(in vitro) studies.
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OVERVIEW OF PANCREATOGENESIS
Pancreas is a derivative of the endoderm germ layer
that is formed during the process of gastrulation on em-
bryonic days (E) 6.5 – 7.5 of the mouse. Definitive endo-
derm forms the primitive gut tube along anterior-poste-
rior axes of an embryo on E 8.5. In the anterior region of
the tube (foregut), two cell thickenings, about a hundred
of cells each, arise both ventrally and dorsally (E 9).
These regions are considered to be pancreatic primor-
dium because endodermal cells of the region acquire
unique developmental program directing the differenti-
ation towards pancreatic fate. During the subsequent
process of budding, primordial epithelial monolayers pro-
liferate and form dorsal (E 9.5) and ventral (E 10.5)
evaginations, referred to as dorsal and ventral stratified
epithelial buds (1) (Figure 1.). It is interesting that ven-
tral and dorsal programs vary considerably, and the de-
velopment is slightly asynchronous because the programs
are initiated by different signals from the surrounding
tissues (2). Dorsal pancreatic bud first gets in close prox-
imity of the notochord and thereafter dorsal aorta takes
up the major role in patterning of the prepancreatic tis-
sue (2). During ventral budding, the endoderm epithe-
lium is first intimately connected with liver and bile duct
epithelium, which is afterwards displaced by cardiac me-
soderm. Pancreatic mesenchyme influences both ventral
and dorsal bud, mainly through proliferative signaling
(2). It is noteworthy that pancreatic program in ventral
pancreatic region is engaged when inhibitory effect of
cardiac mesoderm that operates through FGF and BMP
signaling is avoided by spatial distancing (3, 4), indicat-
ing that pancreatogenesis is a default pathway in ventral
bud. In contrast, signals from notochord (repression of
Shh transduction) and dorsal aorta (VEGF signaling)
promote dorsal pancreas development (5, 6, 7, 8). After
definition of the two buds they continue to grow due to
strong proliferation of pancreatic mesenchyme that un-
derlies multilayered stratified ephitelium. Almost all epi-
thelial cells display characteristics of common endocrine
and exocrine cell precursors (9, 10, 11). At the same time
the process of branching is initiated by intraepithelial
tubulogenesis resulting in the formation of pancreatic
ducts that drain exocrine products in the adult organism
(E 10.5-11). On E 13.5 two pancreatic buds fuse and
form a single organ with fully developed exocrine and
endocrine cells that afterwards assemble and form orga-
nized structures: exocrine acini on E 15.5 and islets of
Langerhans on E16 (1) (Figure 1).
During the process of differentiation, the cascade of
numerous signaling molecules is engaged, and each
member of the signaling network is activated at a partic-
ular time point in a particular cell type (1). Therefore it is
essential to identify spatial and temporal requirements
for transcription factors that could serve as high specific-
ity molecular markers during specification, proliferation
and directed differentiation of ES cells in vitro. Impor-
tance of molecular stage identification is even more pro-
nounced since the anatomy and morphology of cell
structures grown in cultures are often completely incom-
parable with the structures existing in vivo. This review
presents current knowledge on three transcription fac-
tors that are apparently the most suitable markers for the
most significant stages in b-cell development (Figure 1).
Pdx1 is a transcription factor –
regulatory circuit in differentiated
pancreatic cells
Pancreatic and duodenal homeobox gene 1 (pdx1) en-
coding homeodomain transcription factor was classified as
a member of the Hox-like homeobox containing group
(ParaHox gene cluster) (12). It operates at different time
points during pancreatic development. At early stages (E
8.5) pdx1 is activated in the dorsal endoderm of the gut,
and this activation is the first sign of specification toward
pancreatic fate (13). On E 9.5 pdx1 expression is detect-
able within dorsal and ventral pancreatic buds as well as
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Figure 1. Schematic diagram of pancreatic development in the mouse. Approximate embryonic age (in days) is designated for each stage of development.
duodenal endoderm (13). At that point, Pdx1+ cells make
pluripotent population that gives rise to all cell types of
the neonatal pancreas (endocrine, exocrine and duct)
(Figure 3) and epithelium of the duodenum and poste-
rior stomach (13, 14). Later in fetal development, pdx1 is
strongly expressed in beta cell lineage progenitors and
plays a major role in specific differentiation toward beta
cells (13, 15). Finally, in the adult pancreas, Pdx1 is es-
sential in maintaining beta cell function. It activates
transcription of several genes involved in glucose homeo-
stasis including insulin, glucokinase and glucose trans-
porter GLUT2 (16, 17, 18, 19, 20).
Targeted disruption of pdx1 in mice results in arrested
pancreatic development. Soon after initial pancreatic bud
formation, these rudimentary outgrowths regress. Nul-
lizygous pdx1 mice are therefore apancreatic and die
within a few days after birth (21, 22). Intestingly, pdx1
mutant mice during early embryogenesis generate some
insulin and glucagon coexpressing cells (23), which rai-
ses the possibility of pdx1 independent differentiation of
alpha and beta cells. Using Cre-LoxP tagging system,
Herrera (10) clearly demonstrated that double hormone
positive cells do not give rise to mature islet cells. The an-
swer to the next obvious question, i.e. whether any other
Pdx1 negative cell type contributes to adult pancreatic
tissue was given by Gu et al. who also used Cre-LoxP sys-
tem to show that pancreatic tissue is derived exclusively
from Pdx1 positive progenitors (9).
Since pdx1 null mutants exhibit a complete arrest in
pancreatic development, another model of conditional
inactivation helped to elucidate the necessity of continuous
pdx1 expression throughout the process of pancreatoge-
nesis. Tetracycline-induced inactivation of pdx1 on E 11.5
(a time point which precedes strong proliferation and
terminal differentiation of immature endocrine and exo-
crine cells) resulted in animals with undeveloped pan-
creas consisted only of large ducts and primitive epithe-
lium, lacking both acinar and islet tissue (24). On the
other hand, combined forced expression of Pdx1 and
Ptf1a (basic helix–loop–helix transcription factor involv-
ed in exocrine differentiation) is sufficient for conversion
of extrapancreatic endoderm into endocrine and exo-
crine pancreatic progenitors (25). Besides continuous ex-
pression of Pdx1, it has been demonstrated recently that
the tight regulation of the gene activity is also essential
for pancreas development (26).
The best of the Ngn3
Neurogenin 3 (Ngn3) is a member of the basic he-
lix–loop–helix transcription factor family that includes
important transcriptional regulators of the cell fate deter-
mination in a number of cell types. In the mammalian
species, Ngn3 is involved in determination of neural pre-
cursor cells and common precursors of all pancreatic en-
docrine cell types (27, 28) (Figure 3). Ngn3 positive cells
are scattered within the pancreatic epithelium and their
number peaks on E 15.5 during genesis of all four endo-
crine cell types. Afterwards, ngn3 expression gradually
diminishes and ceases completely in the adult pancreas
(29, 30, 31). Ngn3 deficient mice (homozygous null-mu-
tants) lack Langerhans islets and die shortly after birth
although exocrine tissue and pancreatic ducts are nearly
normal. Moreover, not one islet cell type or endocrine
precursor is detectable at any stage of pancreas develop-
ment. These observations indicate that Ngn3 is required
for endocrine fate determination and can therefore be
characterized as a functional marker of islet precursor
cells in the developing mouse pancreas (28). The role of
Ngn3 as an early endocrine marker was further demon-
strated by its ectopic expression under the regulatory
control of the pdx1 promoter in transgenic mice (29).
Actually, forced ngn3 expression causes premature differ-
entiation of common pancreatic precursors (exocrine and
endocrine) into endocrine cells. The resulting »organ«
has poorly branched pancreatic buds with a few endo-
crine-like cells and without the capacity to differentiate
into exocrine tissue. Recently, Johansson and coworkers
(32) generated ngn3 (–/–) mice expressing only tamoxi-
fen-inducible ngn3 under the control of the pdx1 pro-
moter. Early activation of ngn3 almost exclusively induced
glucagon cells, while depleting the pool of pancreas pro-
genitors. There is a number of studies that identify
neuroD1 (gene for another basic helix–loop–helix tran-
scription factor) (28, 33, 34, 35) and a recent study identi-
fying IA1 (gene for a zinc-finger transcription factor (36)
as a direct genomic targets of Ngn3. Three gene products
share very similar expression pattern: NeuroD1 main-
tains the pro-endocrine differentiation program initiated
by Ngn3 and is required for the survival and terminal
differentiation of beta cells; IA1 is required for normal
differentiation of all endocrine cell types.
Ngn3 is presumably involved in the process of lateral
specification by forming a negative cross-regulatory
feedback loop between neighboring cells. At certain time
point during differentiation of common pancreatic pre-
cursors, endocrine and exocrine precursors segregate. At
first, there are a few Ngn3+ cells scattered within the
prepancreatic tissue. After reaching a certain threshold,
Ngn3 turns on Notch ligand genes such as delta-like 1,
which is thought to suppress differentiation in the sur-
rounding cells. This mechanism is mediated by activa-
tion of Hes1 which is a direct repressor of the ngn3 gene
(37) and hence the major negative regulator of endocrine
cell commitment (38). Lateral inhibition could therefore be
responsible for control and modulation of the number of
endocrine cells that are generated (29, 30, 39) (Figure 2).
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Figure 2. Lateral inhibition.
Role of Pax4 in pancreatic b/D-cell
development
Pared box gene 4 (pax4) is a paired domain homeobox
gene (containing both a paired domain and a homeo-
domain), a member of a common subclass of the Pax-
gene family (40, 41, 42). Expression of pax4 begins early
in the development of embryonic pancreas (E 9.5), peaks
on E 13.5 and becomes undetectable in adult islets (43).
It appears that pax4 is a direct target of Ngn3 (39, 44)
since Ngn3 was found to bind and transactivate pax4
promoter (45, 46). Moreover, kinetics of pax4 expression
closely follows that of ngn3. Homozygous pax4 deficient
mice completely lack beta and delta cells and die within
three days of birth (47). The indicates that Pax4 plays an
essential role in sub-specification of beta and delta cell
types within the endocrine progenitor pool during the
development of islet cells (47, 48, 49) (Figure 3).
Interestingly, loss of pax4 does not affect differentiation
of endocrine progenitors toward alpha cell lineage since
knock out animals even have an increased number of al-
pha (43) and epsilon (50) cells. It appears that Pax4 can
function as a transcriptional repressor that may suppress
alpha and permit beta cell differentiation (43). This action
is possibly accomplished through direct or indirect sup-
pression of another transcription factor (Arx) known to
promote alpha cell fate of endocrine progenitors (51).
Moreover, it was shown that Pax4 competes with Pax6
(transcription factor essential for alpha-cell development)
for target sites of the glucagon gene promoter where it acts
as a transcriptional inhibitor (51). It is therefore likely that
Pax4 plays a role in restricting glucagon gene expression to
alpha cells during pancreas development (52).
CONCLUSION
For identification of three major events in acquiring
beta cell identity, three intermediate cell types are now
possible to distinguish according to highly specific, tran-
siently expressed transcription factors: Pdx 1 as a marker
of common pancreatic progenitors, Ngn 3 as a marker of
common endocrine progenitors, and Pax 4 as a marker of
committed beta cell precursors. These findings are of
paramount importance not only for studying pancreas
development, but also in an attempt to obtain insu-
lin-producing cells in vitro with a final goal to improve
diabetes mellitus treatment.
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